Maternal & Public Health
Charlotte Lozier Institute
Public Health Threat: Chemical Abortion Leads to Significantly Higher Rate of ER Visits
As the Food and Drug Administration (FDA) works toward a December 16 decision on chemical abortion safeguards, a groundbreaking new study from Charlotte Lozier Institute (CLI) shows that increased access to abortion pills creates a significant public health risk.
Charlotte Lozier Institute
